NT Health Research and Publications Online

Title
Bronchiectasis among Australian Aboriginal and non-Aboriginal patients in the regional and remote population of the Northern Territory of Australia.
Publication Date
2021-04-01
Author(s)
Mehra, Sumit
Chang, Anne
Lam, Chor K
Campbell, Stuart
Mingi, Joy
Thomas, Izaak
Harwood, Suzanne
Maguire, Graeme
Heraganahally, Subash
Affiliation
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia; and Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gardiner Hospital, Perth, Western Australia, Australia dr.sumitmehra1@gmail.com.
Child Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia; Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia; and Center of Children's Health Research, Australian Centre For Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia anne.chang@menzies.edu.au.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia; and College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia lammaree@gmail.com.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia; Department of General Medicine, Gold Coast University Hospital, Southport, Queensland, Australia; and School of Medicine, Griffith University, Southport, Queensland, Australia stuartc345@gmail.com.
Department of Public Health, Charles Darwin University, Darwin, Northern Territory, Australia; and Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia joyjjose@yahoo.com.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia izaakh.thomas@nt.gov.au.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia suzanne.harwood@malala.com.au.
Melbourne Medical School, The University of Melbourne, Victoria, Australia graeme.maguire@wh.org.au.
Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; and Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia hssubhashcmc@hotmail.com.
Subject
Australia
Indigenous
adults
bronchiectasis
chronic obstructive pulmonary disease
lung function test
Aboriginal
MESH subject
Bronchiectasis
Haemophilus influenzae
Humans
Middle Aged
Northern Territory
Pulmonary Disease, Chronic Obstructive
Retrospective Studies
Type of document
Journal Article
Entity Type
Publication
Abstract
INTRODUCTION: Chronic respiratory disorders are highly prevalent among Australian Aboriginal people living in the Top End Health Service region in the Northern Territory, Australia. Bronchiectasis is a heterogenous disease that features among these chronic respiratory conditions in this population. However, there are sparse comparative data between Aboriginal and non-Aboriginal patients with bronchiectasis from this region. METHODS: In this retrospective study, demographics, clinical characteristics and relevant laboratory parameters were compared among adult Aboriginal and non-Aboriginal patients diagnosed with bronchiectasis between 2012 and 2017. RESULTS: A total of 388 adults had radiology-confirmed bronchiectasis and 258 (66%) were Aboriginal. Compared to non-Aboriginal patients, Aboriginal patients were significantly younger (mean age 54 v 67 years), the majority lived in rural and remote communities (80% v 9 %), had higher rates of self-reported smoking (52% v 19%), alcohol consumption (29% v 12%) and co-occurrence of chronic obstructive pulmonary disease (65% v 38%) and other chronic co-morbidities. Sputum microbiology was also different between the groups with Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis being more common in Aboriginal patients, while Pseudomonas aeruginosa, Aspergillus species and non-tuberculous mycobacteria were higher in non-Aboriginal patients. Further, Aboriginal patients had poorer lung function compared to non-Aboriginal patients (forced expiratory volume after 1 second predicted 33% v 53%, forced vital capacity predicted 49% v 60% respectively), higher exacerbation rates (29% v 18%) and poorer overall outcomes (age at death 60 v 76 years). CONCLUSION: Within a single health service, Aboriginal patients with bronchiectasis have significantly poorer outcomes with differing manifestations and higher comorbidities than non-Aboriginal patients. This warrants further studies to identify feasible interventions to reduce this inequity.
Link
Citation
Rural Remote Health . 2021 Apr;21(2):6390. doi: 10.22605/RRH6390. Epub 2021 Apr 10.
ISSN
1445-6354
1445-6354
Pubmed ID
https://pubmed.ncbi.nlm.nih.gov/33836129/?otool=iaurydwlib

Files:

NameSizeformatDescriptionLink
Bronchiectasis among Australian Aboriginal and non-Aboriginal patients in.pdf 887.423 KB application/pdf Re-used under a Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ View document